This page lists all pharmaceutical reports related to the field of Neurodegenerative & Neuroelectrophysiological Disorders. The reports include market research reports and pipeline analyses.
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Neuroprotection - Drugs, Markets and Companies
- Nitric Oxide - Therapeutics, Markets and Companies
- Alzheimer disease - new drugs, markets and companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- Cell Therapy - Technologies, Markets and Companies
- Stem Cell Markets
- World Neurodegeneratives Disease Markets, 2005-2009
- Cannabinoid Market Forecasts & Analysis to 2012
- Pipeline Insight: Multiple Sclerosis - The oral revolution
- Early Toxicology: Markets and Approaches
- Multiple Sclerosis World Market Outlook to 2011
- Multiple Sclerosis - Disease-modifying efficacy and side effects guide treatment
- Alzheimer's Disease - Prescribing trends indicate that neurologists are not adhering to guidelines
- Pipeline Insight: Epilepsy - Pipeline drugs struggle to outshine their marketed predecessors
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Parkinson's Disease and Restless Legs Syndrome - Reformulations set to drive near-term growth
- Parkinson's Disease - Review of Key Commercial Opportunities in the Symptomatic Treatment Market
- From Blockbuster to Nichebuster
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007
- Therapeutic Vaccines
- Pipeline and Commercial Insight: Alzheimer’s Disease
- Neuroprotection in Stroke
- Renovis' NXY-059 - Safety profile and unmet need could drive approval
- Pipeline Insight: Acute Stroke - Considerable unmet need is balanced by substantial commercial risk
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Multiple Sclerosis - Continued growth makes the MS market a highly attractive investment
- Drug Discovery Tools for High-Content Analysis
- Personalized Medicine
- MULTIPLE SCLEROSIS - Therapy Area Pipeline Report
- ISCHEMIA - Therapy Area Pipeline Report
- STROKE - Therapy Area Pipeline Report
- ALZHEIMER DISEASE - Therapy Area Pipeline Report
- EPILEPSY - Therapy Area Pipeline Report
- PARKINSON DISEASE - Therapy Area Pipeline Report
- SEIZURES - Therapy Area Pipeline Report
- Pipeline and Commercial Insight: Parkinson's Disease
- Commercial Insight: Epilepsy
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Stakeholder Insight: Acute Stroke - TPA spurs infrastructure changes for the better
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The CNS Market Outlook
- Multiple Sclerosis Market Analysis and Forecasts Report 2007-2022
- Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia
- Pipeline Insight: Orphan Diseases in CNS - Huntington's Disease
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Coxibs - Past Problems and Future Potential
- Tysabri - Can Efficacy of VLA-4 Mechanism Overcome Safety Concerns?
- Commercial Insight: Parkinson's Disease - Increased Focus on Earlier Treatment and Managing Levodopa
- Commercial Perspectives: Multiple Sclerosis - How to Find Opportunities in an Unremitting Market
- Alzheimer's Disease - Diagnosis, Disease Modification and Prevention Key to Growing Market
- The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- Innovations in CNS: Novel therapeutics and future R&D strategies
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline Insight: Orphan Diseases in CNS - Amyotrophic Lateral Sclerosis
- Parkinson's Disease - Evidence of neuroprotection essential to progress treatment dynamics
- How to Conduct Clinical Trials in China
- Alzheimers Disease Market analysis and forecasts, 2007-2022
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Parkinson's Disease Market analysis and forecasts
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- Pipeline and Commercial Insight: Alzheimer's Disease
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- CNS Market Overview - neurology, pain and psychiatry
- Neuronal Nicotinic Receptors - April 2008
